Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malin Jarvius

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
BMC Research Notes|April 24, 2019
Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibitionKristin Blom, Jenny Rubin, Malin Berglund, et al.
Immunopharmacology and Immunotoxicology|May 6, 2017
The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activationKristin Blom, Wojciech Senkowski, Malin Jarvius, et al.
Experimental Cell Research|November 7, 2017
Targeting tumor cells based on Phosphodiesterase 3A expressionMadiha Nazir, Wojciech Senkowski, Frida Nyberg, et al.
Scientific Reports|August 6, 2020
Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathwayClaes R Andersson, Tove Selvin, Kristin Blom, et al.
Nature Methods|October 31, 2006
Direct observation of individual endogenous protein complexes in situ by proximity ligationOla Söderberg, Mats Gullberg, Malin Jarvius, et al.
Cancer Research|January 25, 2017
Mouse Models of Pediatric Supratentorial High-grade Glioma Reveal How Cell-of-Origin Influences Tumor Development and PhenotypeSmitha Sreedharan, Naga Prathyusha Maturi, Yuan Xie, et al.
BMC Cancer|August 8, 2013
Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistanceMårten Fryknäs, Joachim Gullbo, Xin Wang, et al.
Nature Communications|April 26, 2022
Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survivalXi Lu, Naga Prathyusha Maturi, Malin Jarvius, et al.
Molecular & Cellular Proteomics : MCP|June 15, 2007
In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation methodMalin Jarvius, Janna Paulsson, Irene Weibrecht, et al.
Biochemical Pharmacology|November 9, 2013
AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemiaAnna Eriksson, Antonia Kalushkova, Malin Jarvius, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
BMC Research Notes|April 24, 2019
Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibitionKristin Blom, Jenny Rubin, Malin Berglund, et al.
Immunopharmacology and Immunotoxicology|May 6, 2017
The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activationKristin Blom, Wojciech Senkowski, Malin Jarvius, et al.
Experimental Cell Research|November 7, 2017
Targeting tumor cells based on Phosphodiesterase 3A expressionMadiha Nazir, Wojciech Senkowski, Frida Nyberg, et al.
Scientific Reports|August 6, 2020
Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathwayClaes R Andersson, Tove Selvin, Kristin Blom, et al.
Nature Methods|October 31, 2006
Direct observation of individual endogenous protein complexes in situ by proximity ligationOla Söderberg, Mats Gullberg, Malin Jarvius, et al.
Cancer Research|January 25, 2017
Mouse Models of Pediatric Supratentorial High-grade Glioma Reveal How Cell-of-Origin Influences Tumor Development and PhenotypeSmitha Sreedharan, Naga Prathyusha Maturi, Yuan Xie, et al.
BMC Cancer|August 8, 2013
Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistanceMårten Fryknäs, Joachim Gullbo, Xin Wang, et al.
Nature Communications|April 26, 2022
Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survivalXi Lu, Naga Prathyusha Maturi, Malin Jarvius, et al.
Molecular & Cellular Proteomics : MCP|June 15, 2007
In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation methodMalin Jarvius, Janna Paulsson, Irene Weibrecht, et al.
Biochemical Pharmacology|November 9, 2013
AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemiaAnna Eriksson, Antonia Kalushkova, Malin Jarvius, et al.
Pageof 4